Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000458396 | SCV000547443 | uncertain significance | Fanconi anemia | 2022-07-12 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 1445 of the SLX4 protein (p.Arg1445Trp). This variant is present in population databases (rs777967898, gnomAD 0.03%). This missense change has been observed in individual(s) with breast and/or ovarian cancer (PMID: 23211700). ClinVar contains an entry for this variant (Variation ID: 407904). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The tryptophan amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV000764053 | SCV000895007 | uncertain significance | Fanconi anemia complementation group P | 2024-03-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004696220 | SCV005194161 | uncertain significance | not provided | criteria provided, single submitter | not provided |